“Frequency and Innovation of New Dermatologic Drugs Approved by US FDA from 2012-2022: A Study with Disclosed Conflicts of Interest for Three Authors”

https://pubmed.ncbi.nlm.nih.gov/38117528

This study analyzed the frequency and innovation of new dermatologic drugs approved by the US FDA from 2012 to 2022, and disclosed conflicts of interest for three authors.